0000810084-14-000001.txt : 20140623 0000810084-14-000001.hdr.sgml : 20140623 20140603173428 ACCESSION NUMBER: 0000810084-14-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140430 FILED AS OF DATE: 20140603 DATE AS OF CHANGE: 20140603 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOJECT MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000810084 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 931099680 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7180 SW SANDBURG STREET, SUITE 100 CITY: TIGARD STATE: OR ZIP: 97223 BUSINESS PHONE: 503-692-8001 MAIL ADDRESS: STREET 1: 7180 SW SANDBURG STREET, SUITE 100 CITY: TIGARD STATE: OR ZIP: 97223 FORMER COMPANY: FORMER CONFORMED NAME: BIOJECT MEDICAL SYSTEMS LTD DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Logomasini Mark CENTRAL INDEX KEY: 0001480077 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15360 FILM NUMBER: 14888637 MAIL ADDRESS: STREET 1: 20245 SW 95TH AVENUE CITY: TUALATIN STATE: OR ZIP: 97062 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2014-04-30 0 0000810084 BIOJECT MEDICAL TECHNOLOGIES INC BJCT 0001480077 Logomasini Mark 7180 SW SANDBURG STREET, SUITE 100 TIGARD OR 97223 1 1 1 0 President and CEO Series I Preferred Stock 0.075 2014-04-30 4 P 0 8287467 0.075 A 2014-04-30 Common Stock 8287467 13524753 I SEP No expiration date. Holdings: 11,173 shares of Series H Preferred Stock convertible into 3,192,286 shares of Common Stock. 62,156 shares of Series I Preferred Stock convertible into 8,287,416 shares of Common Stock held indirectly in SEP Fund. Option for 45,000 shares of Common Stock at $0.15 expiring June 9, 2017 and Option for 2,000,000 shares of Common Stock at $0.06 expiring February 14, 2023. //Christine M. Farrell Attorney-in-Fact for Mark Logomasini// 2014-06-03